Recently Released Market Study: Gamma Therapeutics, Inc. - Product Pipeline Analysis
Gamma Therapeutics, Inc. (Gamma Therapeutics), an early stage biotechnology company. It focuses on developing solutions for cardiovascular disease risk assessment, surgical therapy and combat casualty care. The company's flagship product includes, GammaCoeur, a cardiovascular disease diagnostic assay for prognosis and preventative care. It also offers GammaSeal, a natural surgical sealant for large artery vascular surgery and Gammarin, a non-immunogenic anti-coagulant blood thinner for post-surgical venous thromboembolism control which are currently under development. The company's products are based on Gamma Prime...
View full press release